Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
BelgiumStudy on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment
AustriaStudy on the Long-term Effects of Dupilumab for Patients with Aspirin-Exacerbated Respiratory Disease (AERD)
AustriaStudy on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease
GermanyStudy Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration
CzechiaStudy on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection
FranceStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on the Safety and Effects of Baricitinib in People with HIV
SpainStudy on the Effects of Sunobinop on Reducing Alcohol Consumption in Patients with Moderate to Severe Alcohol Use Disorder Seeking Treatment
RomaniaStudy on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis
BulgariaStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
BelgiumStudy on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
